irbesartan/atorvastatin fixed-dose combination
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for irbesartan/atorvastatin fixed-dose combination, covering 2022-04-13 to 2022-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension [Phase 4]